View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 31, 2018

Ava secures new funding to advance fertility tracking bracelet

Swiss medical technology company Ava has raised $30m in a strategic Series B funding round led by European VC firm btov, to advance its fertility tracking sensor bracelet for women.

Swiss medical technology company Ava has raised $30m in a strategic Series B funding round led by European VC firm btov, to advance its fertility tracking sensor bracelet for women.

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

The financing round was joined by Credit Suisse ’s investment vehicle SVC and Ava ’s existing investors.

“The company plans to use the new funds to drive research and development for advancing the cycle-tracking device.”

Ava designed its sensor bracelet to accurately identify the 5.3-day fertile window in a woman’s cycle in real-time. The company plans to use the new funds to drive research and development for advancing the cycle-tracking device.

In addition, Ava intends to devise new applications targeting the reproductive health of women through data insights and science.

Ava co-founder Pascal Koenig said: “Ava ’s long-term vision is to accompany women through all stages of their reproductive life by providing data-driven, clinically proven technology that will make a woman’s life easier, healthier and better — be it when they just want to understand their body, while they are trying to prevent pregnancy, trying to get pregnant, are pregnant or entering menopause.”

The company is currently performing various clinical trials to evaluate its technology at the University Hospital of Zurich led by professor Brigitte Leeners.

These studies aim to help women who are trying to get pregnant or having fertility challenges. Ava also wants to gain better insights into complications that occur during pregnancy.

Leeners said: “Combining the best in science, data insights and technology is not only helping to create families but improving women’s lives around the world.”

Related Companies

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network